Interim Professionals - May 9, 2025

ERP and APS Systems Implementation Support as Planning SME

By Lujain Mousa

A rapidly growing biotech company reaching US $500M+ in revenue required an accelerated implementation of the supply chain modules of their ERP system, as well as implementation of an advanced (scenario) planning system. The knowledge, bandwidth and experience required for these activities surpassed the capacity of the team managing day-to-day operations. AIM was able to deliver and experienced resource in the field of planning systems (implementation) who has supported the definition of critical planning processes, and the implementation of the systems required to run them.

Cell & Gene - May 9, 2025

Ongoing Part-time Support in Artwork and Serialization for (Start-up) Biotech Companies

By Lujain Mousa

The effective and efficient management of artwork and (operational) serialization processes is essential in any biopharma company, including (start-up) biotechs. These specialized activities rarely require full-time resources, which is a challenge for especially start-up companies. AIM supports multiple clients with flexible and long-term arrangements providing expert guidance on artwork compliance, implementation of serialization processes meeting global standards, and advisory on evolving requirements and process optimization. This model gives clients access to specialized expertise precisely when needed without the overhead of full-time positions. Employees can focus on other core activities while ensuring compliance in these technical but essential areas, providing continuity throughout their growth journey.

Interim Professionals - May 9, 2025

Interim Supply Chain Management at Midsize Biotech While Hiring Supply Chain Leadership

By Lujain Mousa

When this midsize biotech’s search for a new Supply Chain Director extended beyond expected timelines, they needed leadership during a period of ongoing geographic expansion while managing upstream supply chain tensions. AIM provided an experienced Supply Chain Director with extensive biotech background who immediately led the department, building critical relationships with commercial, quality and finance stakeholders, and addressed supply vulnerabilities. Our consultant successfully bridged this critical 6-month gap. When the permanent Director joined, they inherited a well-functioning team, ensuring a smooth transition without operational disruption.